Earnings Week Kicks Off With Bears in Charge
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Bears Dig In
Short sellers are adding pressure across multiple names heading into a massive earnings week. Hertz short interest hit 84.6% of free float — up nearly 10 points in seven days. Chewy is right behind at 82.4%, with zero shares available to borrow. Both names carry extreme squeeze risk once results land.
Palantir kicks off the week with results after today's close. The AI-data firm holds a $283 billion market cap. Bears and bulls are both watching closely for demand signals as AI spending competition heats up.
Big Prints Coming
Tuesday is the busiest day. AMD reports after the close — AI GPU demand is the central question. Caterpillar hits pre-market, with results seen as a read on global construction health. Merck also releases Tuesday amid drug pricing pressure.
Wednesday brings Eli Lilly, the $1 trillion pharma leader. GLP-1 drug sales dominate the agenda.
Analyst Moves
Three downgrades landed this morning. Bristol-Myers Squibb, Johnson Controls, and Zebra Technologies all saw bearish revisions. Amazon stood out on the other side — its average target price was lifted to $321.95. All 59 covering analysts remain bullish.
Canada: WestJet Strike
Flight attendants at WestJet walked off the job today in a pay dispute. The action hit Air Canada in sympathy, drawing fresh attention to Canadian aviation labor costs.
Insider Watch
Charles Schwab's founder filed sales of over $20.8 million in SCHW stock this week. Three separate filings between July 28–30. That cluster of exits at America's biggest brokerages is worth noting going into results season.
Stocks in this article
How this article was generated
- Generated
- 2 Aug 2026, 08:50
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowORTEX Alpha signalsORTEX Alpha signalsAnalyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.